Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 10/25: (DRE) (LOW) (RGLD) Upgraded; (NFLX) (HWAY) (CEDC) Downgraded(
-
Auriga Starts Nike (NKE) at Buy
-
Auriga Upgrades Xilinx (XLNX) to Buy
-
Auriga Starts AAR Corporation (AIR) at Hold, $20 Price Target
-
Auriga Starts HEICO (HEI) at Buy, $62 Price Target
-
Auriga Starts Esterline Tech (ESL) at Buy, $80 Price Target
-
Auriga Starts TransDigm (TDG) at Buy, $100 Price Target
-
Auriga Reiterates a 'Buy' on Medidata Solutions (MDSO); Solid as a Rock; Accounting Distractions & Macro Not Helping
-
Auriga Upgrades Computer Programs and Systems (CPSI) to Buy; Rural Health Initiative Should be Advantageous
-
Auriga Starts Universal Stainless & Alloy (USAP) at Buy
-
Auriga Starts Globe Specialty Metals (GSM) at Buy
-
Auriga Starts Haynes International (HAYN) at Buy
-
Auriga Starts GrafTech International (GTI) at Buy
-
Auriga Reiterates a 'Buy' on Lululemon Athletica (LULU); Debut for Ivivva Athletica in the US?
-
Auriga reiterates a 'Buy' on First Solar (FSLR); DoE Loan Guarantees Aid Revenue & Earnings Visibility
-
Auriga Reiterates a 'Buy' on SunPower (SPWRA); DoE Loan Guarantee Aids Revenue & Earnings Visibility
-
Auriga Maintains a 'Hold' on OCZ Technology Group (OCZ); Expect a Solid Earnings Report
-
Notable Analyst Rating Changes 09/30: (CEVA) (MOS) (MRO) Upgraded; (CZZ) (ALTR) (MU) Downgraded
-
Auriga Downgrades Altera (ALTR) to Hold; Rising Opex, Weak Macro, 28nm and Inventory Correction
-
Auriga Starts Salix Pharmaceuticals (SLXP) at Hold; Growth Gastrointestinal Drug Company, But Share Price Appears Properly Valued
-
Auriga Labels Jazz Pharmaceuticals (JAZZ) as Successful Orphan Drug Story; Starts Coverage at 'Buy'
-
Auriga Starts DepoMed (DEPO) at Buy; Proven Drug Delivery Technology
-
Auriga Starts Spectrum Pharmaceuticals (SPPI) at Buy; Fast-Growing Cancer Therapy Company
-
Auriga Starts 3SBio (SSRX) at Hold; High Growth Biotech Company in China, But Fairly Valued
-
Auriga Maintains a 'Buy' on Seagate Technology (STX); Lowering Estimates & Price Target
-
Auriga Maintains a 'Buy' on Western Digital (WDC); Should Stand Out Again
-
Auriga reiterates a 'Buy' on EMC (EMC); Still Like Long-Term, Though the Quarter Looks Mixed
-
Auriga on Solar Photovoltaics: Revising All Price Targets
-
Auriga Starts Medifast (MED) at Buy; Robust Growth Should Continue with Expansion of Weight Control Centers
-
Auriga Starts Nutrisystem (NTRI) at Buy; New Initiatives Could Spice Up Future Earnings
-
Auriga Starts Weight Watchers (WTW) at Buy; Lower Price Is Something To Chew On
-
Auriga Starts Constellation Brands (STZ) at Buy; More Focused Portfolio May Break Shares Out of Box
-
Auriga Starts Boston Beer Company (SAM) at Hold; Freshest Beer Program to Negatively Impact Shipments
-
Auriga Maintains a 'Buy' on Marvell (MRVL); Reducing Estimates on Weaker Macro Trends
-
Auriga reiterates a 'Buy' on Hewlett-Packard (HPQ); Advice to Meg Whitman
-
Auriga Maintains a 'Buy' on Cavium Networks (CAVM); Reducing Target as CSCO/Enterprise Correction Leads to Lowered Guidance
-
Auriga Starts Steven Madden (SHOO) at Buy
-
Auriga Starts DSW Inc. (DSW) at Buy
-
Auriga Starts Deckers Outdoor (DECK) at Buy
-
Auriga Starts Lululemon Athletica Inc. (LULU) at Buy
-
Auriga Starts Skechers USA (SKX) at Hold
-
Auriga Reiterates a 'Buy' on First Solar (FSLR); Cost Leadership Intact; Visibility on Track
-
Auriga Maintains a 'Buy' on Omnicell (OMCL); Still Buyers Near-Term, but 2012 Contains Headwinds
-
Auriga Downgrades Xilinx (XLNX) to Hold; 28nm Promising, But Near-Term Remains Challenging
-
Auriga maintains a 'Buy' on Juniper Networks (JNPR); Attractive Valuation, but New Products Likely Require More Patience
-
Auriga Downgrades EZchip Semiconductor (EZCH) to Hold; Moving to the Sidelines on Valuation and Higher Risk
-
Auriga Starts Trina Solar (TSL) at Buy
-
Auriga Starts Suntech Power (STP) at Sell
-
Auriga Starts Yingli Green Energy (YGE) at Sell
-
Auriga Maintains a 'Buy' on Cisco (CSCO); Conservative Targets, Bullish Undertones

